Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.

Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.

Item
http://www.wikidata.org/entity/Q37544974
Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adultsVirulence Factors of Streptococcus pneumoniae. Comparison between African and French Invasive Isolates and Implication for Future VaccinesSafety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life.Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians.Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life.
P2860

Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults.

Item
http://www.wikidata.org/entity/Q37544974
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety, immunogenicity, and an ...... olled study in healthy adults.
@en
Safety, immunogenicity, and an ...... olled study in healthy adults.
@nl
type
label
Safety, immunogenicity, and an ...... olled study in healthy adults.
@en
Safety, immunogenicity, and an ...... olled study in healthy adults.
@nl
prefLabel
Safety, immunogenicity, and an ...... olled study in healthy adults.
@en
Safety, immunogenicity, and an ...... olled study in healthy adults.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Safety, immunogenicity, and an ...... rolled study in healthy adults
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932